Pulse lineResearch With Heart Logo

Resistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study.

TitleResistance to antihypertensive treatment and long-term risk: The Atherosclerosis Risk in Communities study.
Publication TypeJournal Article
Year of Publication2021
AuthorsWijkman MO, Malachias MVB, Claggett BL, Cheng S, Matsushita K, Shah AM, Jhund PS, Coresh J, Solomon SD, Vardeny O
JournalJ Clin Hypertens (Greenwich)
Volume23
Issue10
Pagination1887-1896
Date Published2021 10
ISSN1751-7176
KeywordsAntihypertensive Agents, Atherosclerosis, Blood Pressure, Humans, Hypertension, Myocardial Infarction, Risk Factors
Abstract

More stringent blood pressure (BP) goals have led to greater prevalence of apparent resistant hypertension (ARH), yet the long-term prognostic impact of ARH diagnosed according to these goals in the general population remains unknown. We assessed the prognostic impact of ARH according to contemporary BP goals in 9612 participants of the Atherosclerosis Risk in Communities (ARIC) study without previous cardiovascular disease. ARH, defined as BP above goal (traditional goal
DOI10.1111/jch.14269
Alternate JournalJ Clin Hypertens (Greenwich)
PubMed ID34547175
PubMed Central IDPMC8678845
Grant ListHHSN268201700001I / HL / NHLBI NIH HHS / United States
R01 HL150342 / HL / NHLBI NIH HHS / United States
HHSN268201700004I / HL / NHLBI NIH HHS / United States
R01 HL135008 / HL / NHLBI NIH HHS / United States
K24 HL152008 / HL / NHLBI NIH HHS / United States
HHSN268201700005I / HL / NHLBI NIH HHS / United States
HHSN268201700003I / HL / NHLBI NIH HHS / United States
R01 HL143224 / HL / NHLBI NIH HHS / United States
HHSN268201700002I / HL / NHLBI NIH HHS / United States
R01 HL148218 / HL / NHLBI NIH HHS / United States